Cargando…
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
Zika virus (ZIKV) is a major public health concern due to the risk of congenital Zika syndrome in developing fetuses and Guillain-Barre syndrome in adults. Currently, there are no approved vaccines available to protect against infection. Adenoviruses are safe and highly immunogenic vaccine vectors c...
Autores principales: | Bullard, Brianna L., Corder, Brigette N., Gorman, Matthew J., Diamond, Michael S., Weaver, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301965/ https://www.ncbi.nlm.nih.gov/pubmed/30573745 http://dx.doi.org/10.1038/s41598-018-35755-z |
Ejemplares similares
-
Characterization of a Species E Adenovirus Vector as a Zika virus vaccine
por: Bullard, Brianna L., et al.
Publicado: (2020) -
Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020) -
A Single-Cycle Adenovirus Type 7 Vaccine for Prevention of Acute Respiratory Disease
por: Bullard, Brianna L., et al.
Publicado: (2019) -
A Decade in Review: A Systematic Review of Universal Influenza Vaccines in Clinical Trials during the 2010 Decade
por: Corder, Brigette N., et al.
Publicado: (2020) -
Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017)